The Mediatory Role of Inflammatory Markers on the Relationship Between the NOVA Classification System and Obesity Phenotypes Among Obese and Overweight Adult Women: a Cross-sectional Study

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2024 Jan 1

PMID 38162517

Authors

Mahya Mehri Hajmir

Farideh Shiraseb

Dorsa Hosseininasab

Yasaman Aali

Shabnam Hosseini

Khadijeh Mirzaei

Affiliations

Soon will be listed here.

Abstract

Background: Diet and inflammation both play important roles in the occurrence of obesity. We aimed to investigate the role of inflammation in the development of both metabolically healthy obese (MHO) and metabolically unhealthy obese (MUHO) individuals.

Methods: This cross-sectional study included 221 overweight and obese women aged 18-56 years. The study assessed the metabolic health phenotypes of the participants using the Karelis criterion score. Additionally, dietary intakes were evaluated using a 147-item semi-quantitative questionnaire and the NOVA classification system (comprising 37 food groups and beverages). The study also collected and analyzed the blood parameters, as well as biochemical and anthropometric indices, for all participants.

Results: Among the women included in the study, 22.9% had MHO phenotypes but 77.1% had MUHO phenotypes. A significant association between the third quartile of the NOVA classification system and the increased likelihood of having the MUHO phenotype was observed (OR = 1.40, 95% CI = 1.09-4.92, = 0.04). Regarding the potential role of inflammatory markers, high-sensitivity C-reactive protein (hs-CRP) ( = 0.84), transforming growth factor-β (TGF-β) ( = 0.50), monocyte chemoattractant protein-1 (MCP-1) ( = 0.49), plasminogen activator inhibitor-1 (PAI-1) ( = 0.97), and homeostatic model assessment for insulin resistance (HOMA-IR) ( = 0.92) were found to be mediators.

Conclusion: We observed a significant positive association between ultra-processed food (UPF) consumption and the MUHO phenotype in overweight and obese women. This association appeared to be mediated by some inflammatory markers, such as hs-CRP, TGF-β, MCP-1, PAI-1, and HOMA-IR. Additional studies are needed to validate these findings.

References

Moubarac J, Parra D, Cannon G, Monteiro C . Food Classification Systems Based on Food Processing: Significance and Implications for Policies and Actions: A Systematic Literature Review and Assessment. Curr Obes Rep. 2015; 3(2):256-72. DOI: 10.1007/s13679-014-0092-0. View

Mohamadi A, Shiraseb F, Mirzababaei A, Hosseininasab D, Rasaei N, Clark C . Circulating Inflammatory Markers May Mediate the Relationship between Healthy Plant-Based Diet and Metabolic Phenotype Obesity in Women: A Cross-Sectional Study. Int J Clin Pract. 2022; 2022:8099382. PMC: 9159206. DOI: 10.1155/2022/8099382. View

Seidell J . Epidemiology of obesity. Semin Vasc Med. 2005; 5(1):3-14. DOI: 10.1055/s-2005-871737. View

Tanabe N, Saito K, Yamada Y, Takasawa T, Seki N, Suzuki H . Risk assessment by post-challenge plasma glucose, insulin response ratio, and other indices of insulin resistance and/or secretion for predicting the development of type 2 diabetes. Intern Med. 2009; 48(6):401-9. DOI: 10.2169/internalmedicine.48.1325. View

Mirmiran P, Hosseini-Esfahanil F, Jessri M, Mahan L, Shiva N, Azizis F . Does dietary intake by Tehranian adults align with the 2005 dietary guidelines for Americans? Observations from the Tehran lipid and glucose study. J Health Popul Nutr. 2011; 29(1):39-52. PMC: 3075058. DOI: 10.3329/jhpn.v29i1.7564. View

Moradi S, Entezari M, Mohammadi H, Jayedi A, Lazaridi A, Kermani M . Ultra-processed food consumption and adult obesity risk: a systematic review and dose-response meta-analysis. Crit Rev Food Sci Nutr. 2021; 63(2):249-260. DOI: 10.1080/10408398.2021.1946005. View

van Vliet-Ostaptchouk J, Nuotio M, Slagter S, Doiron D, Fischer K, Foco L . The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014; 14:9. PMC: 3923238. DOI: 10.1186/1472-6823-14-9. View

Vafeiadi M, Myridakis A, Roumeliotaki T, Margetaki K, Chalkiadaki G, Dermitzaki E . Association of Early Life Exposure to Phthalates With Obesity and Cardiometabolic Traits in Childhood: Sex Specific Associations. Front Public Health. 2018; 6:327. PMC: 6277685. DOI: 10.3389/fpubh.2018.00327. View

Ranciere F, Lyons J, Loh V, Botton J, Galloway T, Wang T . Bisphenol A and the risk of cardiometabolic disorders: a systematic review with meta-analysis of the epidemiological evidence. Environ Health. 2015; 14:46. PMC: 4472611. DOI: 10.1186/s12940-015-0036-5. View

10.

Shim J, Oh K, Kim H . Dietary assessment methods in epidemiologic studies. Epidemiol Health. 2014; 36:e2014009. PMC: 4154347. DOI: 10.4178/epih/e2014009. View

11.

Rattanarat P, Chindapan N, Devahastin S . Comparative evaluation of acrylamide and polycyclic aromatic hydrocarbons contents in Robusta coffee beans roasted by hot air and superheated steam. Food Chem. 2020; 341(Pt 1):128266. DOI: 10.1016/j.foodchem.2020.128266. View

12.

Sung H, Park J, Oh S, Ha K, Joung H . Consumption of Ultra-Processed Foods Increases the Likelihood of Having Obesity in Korean Women. Nutrients. 2021; 13(2). PMC: 7926298. DOI: 10.3390/nu13020698. View

13.

Hinnouho G, Czernichow S, Dugravot A, Batty G, Kivimaki M, Singh-Manoux A . Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?. Diabetes Care. 2013; 36(8):2294-300. PMC: 3714476. DOI: 10.2337/dc12-1654. View

14.

Lopes A, Araujo L, Levy R, Barreto S, Giatti L . Association between consumption of ultra-processed foods and serum C-reactive protein levels: cross-sectional results from the ELSA-Brasil study. Sao Paulo Med J. 2019; 137(2):169-176. PMC: 9721234. DOI: 10.1590/1516-3180.2018.0363070219. View

15.

Konieczna J, Morey M, Abete I, Bes-Rastrollo M, Ruiz-Canela M, Vioque J . Contribution of ultra-processed foods in visceral fat deposition and other adiposity indicators: Prospective analysis nested in the PREDIMED-Plus trial. Clin Nutr. 2021; 40(6):4290-4300. DOI: 10.1016/j.clnu.2021.01.019. View

16.

Pajunen P, Kotronen A, Korpi-Hyovalti E, Keinanen-Kiukaanniemi S, Oksa H, Niskanen L . Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health. 2011; 11:754. PMC: 3198943. DOI: 10.1186/1471-2458-11-754. View

17.

Yu J, Choi W, Lee H, Lee J . Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults: An observational study. Medicine (Baltimore). 2019; 98(9):e14740. PMC: 6831265. DOI: 10.1097/MD.0000000000014740. View

18.

Cecil J, Tavendale R, Watt P, Hetherington M, Palmer C . An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008; 359(24):2558-66. DOI: 10.1056/NEJMoa0803839. View

19.

Schrager M, Metter E, Simonsick E, Ble A, Bandinelli S, Lauretani F . Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2006; 102(3):919-25. PMC: 2645665. DOI: 10.1152/japplphysiol.00627.2006. View

20.

Basu S, Yoffe P, Hills N, Lustig R . The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS One. 2013; 8(2):e57873. PMC: 3584048. DOI: 10.1371/journal.pone.0057873. View